Whitehawk Therapeutics awarded insider Iyengar Vijay K 76,080 derivative securities on 2026-09-09. The award matters to investors because it left him holding 76,080 derivative securities after the transaction, with the transaction equal to about 100.0% of his resulting derivative securities position.
Key Highlights
- The transaction represented about 100.0% of Iyengar Vijay K’s resulting derivative securities holding.
- Transaction code A classifies the event as an award or grant.
- Iyengar Vijay K’s resulting position was identified as a new insider position.
Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) awarded insider Iyengar Vijay K 76,080 derivative securities on 9 September 2026. The resulting position was reported at 76,080 derivative securities.
76,080 Derivative Securities Awarded
Iyengar Vijay K was the named insider connected with the transaction. The record identified the event as a new insider position. The award date was 9 September 2026. Whitehawk Therapeutics was the company associated with the derivative securities.
Entire Resulting Derivative Position
About 100.0% of Iyengar Vijay K’s resulting derivative securities holding came from the transaction. For investors tracking Whitehawk Therapeutics insider activity, the stated percentage means the award corresponds to the entire resulting derivative position reported after the event. The reported ownership measure is tied specifically to the post-transaction derivative securities holding.
FAQs
Q: What did Whitehawk Therapeutics award Iyengar Vijay K?
A: Whitehawk Therapeutics awarded Iyengar Vijay K 76,080 derivative securities on 9 September 2026. The transaction was classified with code A, meaning an award or grant.
Q: What was the impact on Iyengar Vijay K’s Whitehawk Therapeutics holdings?
A: Iyengar Vijay K held 76,080 derivative securities after the transaction. The award represented about 100.0% of his resulting derivative securities holding.
Q: What does the Whitehawk Therapeutics insider transaction mean for investors?
A: The transaction identifies a new insider position involving 76,080 derivative securities. Investors can also see that the award accounted for about 100.0% of the resulting derivative securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.